IVDR stands for a European regulation, the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746. This regulation, which has been in force since 2017, deals with regulating the marketing and commissioning of medical devices for in vitro diagnosis throughout the territory of the European Union, as well as Northern Ireland after Brexit. This regulation repeals Directive 98/79/EC on medical devices for in vitro diagnostics.
The transition time for in vitro diagnostic medical devices (IVDs) to comply with the EU IVD regulation 2016/746 (IVDR) is coming to an end: IVDR will be fully implemented from May 26, 2022. The new in vitro diagnostic medical devices will be required to comply with the IVDR, while IVDs certified under the IVD directive 98/79/EC (IVDD) will not be valid as of May 27, 2024. Time passes quickly and it must be kept in mind that compliance with the IVDR requires much more work than the IVDD. QSG´s objective is to work together with you to be able to carry out this transition in an organized and planned manner, fulfilling the objectives of the Regulation.
One of the most significant changes introduced by the IVDR is the new classification for IVDs. The IVDR specifies a clear set of rules for classifying IVDs into four risk categories, ranging from Class A (lowest risk) to Class D (highest risk). Manufacturers must determine the IVD class regardless of how it was classified on the IVDD. Annex VIII of the IVDR provides the list of rules required for IVD classification.
It is important that manufacturers of this type of in vitro diagnostic medical device act with time and proper planning, because the new regulation introduces major changes and has a great impact on the industry. IVDR matches the requirements of the Medical Device Regulation (EU) 2017/745.
As mentioned before, the IVDR seeks to achieve greater traceability and higher quality standards, together with an exhaustive performance evaluation report. Some of the main points of changes introduced are mentioned below:
Download the Technical File Structure to comply with the new IVDR for free!
WHAT IS THE “SELL-OFF” PROVISION ABOUT?
The “sell-off” provision is intended to limit the time during which devices that are compliant with the Directive and have already been placed on the market may be made available. Any device that is still within the supply chain and has not reached its end user as ready to use can no longer be used.
ARE PRODUCTS THAT COMPLY WITH THE REGULATION AND THAT ARE PLACED ON THE MARKET SUBJECT TO THE SO-CALLED “SELL OFF” PROVISION OF ARTICLE 110 SECTION 4 OF THE IVDR?
No, the possibility that they continue to be marketed or put into service is not limited in time.
DOES THE IVDR REQUIRE A CLINICAL EVALUATION REPORT?
No, the Clinical Evaluation Report is mandatory only for the MDR. In the case of the IVDR, the Performance Evaluation Report (PER) is a result of the process of performance evaluation activities. PERs for Class C and D devices must be updated at least once a year, while PERs for Class A and B devices must be updated as needed. The recommendation of the notifying bodies is to carry out a review at least every three years.
UNDER THE NEW IVDR, CAN MY DEVICE BE RE CLASSIFIED?
Yes, under the new IVDR every manufacturer must check if their device is still under the same classification or if anything has changed. QSG can support you preparing an EU Regulatory strategy document with your device classification. Also, we have the expertise on guiding you in order to have the device document in compliance with the new Regulation.
WHAT IS THE EUDAMED? AND THE UDI?
EUDAMED is the IT system established by Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on medical device for in vitro diagnostics and developed by the European Commission. The objective of this database is to provide the traceability for each medical device, and to facilitate the flow of information between all the actors (medical devices manufacturers, authorized representatives, importers, distributors, Notified Bodies, EU member states and the European Commission). EUDAMED’s major achievement is the registration of products with a unique UDI (Unique Device Identification).
WHEN DO MEDICAL DEVICE MANUFACTURERS NEED TO COMPLY WITH THE REQUIREMENTS OF THE NEW IVDR?
As of May 26, 2022, manufacturers and new products already had to comply with the new IVDR requirements to be marketed in the European Union. Also, is important to check frequently for due date updates, or contact expert consultants for new potential delays in the implementation.
HOW CAN MANUFACTURERS PREPARE FOR THE NEW IVDR?
To successfully transition from IVDD to IVDR, manufacturers must have a comprehensive and detailed management plan. Quality and Regulatory aspects must be considered, depending on the device classification. It is key for specialized third-party auditors to conduct internal audits in order to have an overview of the quality system and ensure compliance with the IVDR. A GAP analysis to evaluate needs for technical documentation is also a fundamental step.
"*" indicates required fields
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, please see here: Cookie Policy
Explore our revamped website and experience a more user-friendly interface designed to serve you better!
If you have any questions, would like more information, or would like to speak with a QSG representative, please contact us at any time!
Thanks for letting us know!
Please fill in the information below so that we can keep you informed.